Renal Cancer - Results from #20

Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer Specific Mortality and All-Cause Mortality. December 4, 2024

Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size. December 3, 2024

Renal cell carcinoma with inferior vena cava thrombus: Survival and prognostic factors in surgically treated patients. December 3, 2024

STAT2/SLC27A3/PINK1-Mediated Mitophagy Remodeling Lipid Metabolism Contributes to Pazopanib Resistance in Clear Cell Renal Cell Carcinoma. December 2, 2024

Late Survival and Long-Term Follow-Up After Radical Resection of Advanced Renal Cell Carcinoma With Associated Venous Tumor Thrombus. December 2, 2024

Comparison of outcomes between single-port and multi-port robotic radical nephrectomy. November 29, 2024

Adverse events after nivolumab and ipilimumab combined immunotherapy in advanced renal cell carcinoma: a multicentre experience in Poland. November 29, 2024

Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma. November 28, 2024

Calcium Channel Blocker Versus Renin-Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score-Matched Cohort Study. November 28, 2024

Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study. November 27, 2024

Papillary renal cell carcinoma revisited: impact of the World Health Organization 2022 classification on prognostication. November 27, 2024

French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer. November 26, 2024

Synchronized autologous T-cell immunotherapy with hyperthermia to previously heavy treated advanced renal cell carcinoma. November 26, 2024

Association between the systemic inflammation response index and kidney stones in US adults: a cross-sectional study based on NHANES 2007-2018. November 26, 2024

CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and Beyond. November 25, 2024

Risk factors for kidney cancer and socio-occupational category: significant impact of chlorinated solvents (UroCCR 111). November 25, 2024

Robot-assisted partial nephrectomy vs. percutaneous cryoablation for T1a renal tumors: a single-center retrospective analysis of outcomes and costs. November 25, 2024

Decoy-resistant IL-18 reshapes the tumor microenvironment and enhances rejection by anti-CTLA-4 in renal cell carcinoma. November 22, 2024

Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis. November 22, 2024

The Impact of Concomitant Medications on the Overall Survival of Patients Treated with Systemic Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis. November 21, 2024

Page 2 of 456